- Home
- PKBK vs GOSS Comparison
PKBK vs GOSS Comparison
Compare PKBK & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- GOSS
- Stock Information
- Founded
- PKBK 1999
- GOSS 2015
- Country
- PKBK United States
- GOSS United States
- Employees
- PKBK N/A
- GOSS N/A
- Industry
- PKBK Major Banks
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- GOSS Health Care
- Exchange
- PKBK Nasdaq
- GOSS Nasdaq
- Market Cap
- PKBK 227.0M
- GOSS 262.5M
- IPO Year
- PKBK N/A
- GOSS 2019
- Fundamental
- Price
- PKBK $21.33
- GOSS $1.21
- Analyst Decision
- PKBK
- GOSS Strong Buy
- Analyst Count
- PKBK 0
- GOSS 3
- Target Price
- PKBK N/A
- GOSS $7.33
- AVG Volume (30 Days)
- PKBK 25.1K
- GOSS 2.6M
- Earning Date
- PKBK 07-18-2025
- GOSS 08-11-2025
- Dividend Yield
- PKBK 3.40%
- GOSS N/A
- EPS Growth
- PKBK 24.08
- GOSS N/A
- EPS
- PKBK 2.41
- GOSS N/A
- Revenue
- PKBK $64,206,999.00
- GOSS $124,590,000.00
- Revenue This Year
- PKBK N/A
- GOSS N/A
- Revenue Next Year
- PKBK N/A
- GOSS $91.14
- P/E Ratio
- PKBK $8.75
- GOSS N/A
- Revenue Growth
- PKBK N/A
- GOSS N/A
- 52 Week Low
- PKBK $15.44
- GOSS $0.66
- 52 Week High
- PKBK $24.29
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- PKBK 70.28
- GOSS 46.78
- Support Level
- PKBK $20.37
- GOSS $1.20
- Resistance Level
- PKBK $21.38
- GOSS $1.33
- Average True Range (ATR)
- PKBK 0.51
- GOSS 0.10
- MACD
- PKBK 0.18
- GOSS -0.02
- Stochastic Oscillator
- PKBK 98.08
- GOSS 6.12
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.